Get Xospata (Gilteritinib) Approved by Cigna in Washington: Prior Authorization, Appeals & Alternatives
Answer Box: Getting Xospata (Gilteritinib) Covered by Cigna in Washington
Eligibility: Xospata requires prior authorization from Cigna for adults with relapsed/refractory AML who have FLT3-mutated disease confirmed by an FDA-approved test. Fastest path: Have your hematologist submit clinical documentation showing FLT3 mutation positivity, prior therapy failures, and medical necessity